Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Council of Europe defines stem cell policy:

This article was originally published in Clinica

Executive Summary

The Council of Europe's Parliamentary Assembly has adopted a resolution calling on member states to ban the production of human embryos for research, and to promote common European basic research programmes in the field of adult stem cells. In a statement adopted on October 2, the Assembly calls on member states to promote stem cell research on the condition that it respects the life of human beings in any state of their development. Additionally, it has stressed that, in countries where it is allowed, research on stem cells involving the destruction of human embryos is duly authorised and monitored by the appropriate national bodies.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT063827

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel